IPN - Instituto Pedro Nunes - IPN supports early-stage healthcare startups to enter the European market

IPN     IPN Incubadora
IPN supports early-stage healthcare startups to enter the European market
RTD Laboratories
Clique aqui para a versão em português. 

The EIT Health Regulatory Pathways to Market Bootcamp is a 10-week programme that aims to help early-stage health companies enter the European market.

Instituto Pedro Nunes (IPN) is taking part in this EIT Health bootcamp, which is designed to support health innovation companies and help them understand the European health services regulatory market.

To this end, patients, healthcare professionals, taxpayers and regulatory bodies need to understand whether these technologies meet their needs.

This bootcamp is designed to help healthcare innovation companies understand and navigate the European healthcare market. The aim of this programme, which is highly specialised and tailored to the needs of these companies, is to give early-stage start-ups with a focus on medical devices and digital health the tools they need to access this market more easily.

The aim is for companies to acquire tools to develop an efficient go-to-market strategy, such as regulatory strategy, health technology assessment, market entry, reimbursement options and access to funds, and strategic planning in order to access the market with all the requirements already properly in place.

IPN will share its expertise in health technologies, medical devices and regulation, as well as providing guidance and mentoring to participating startups.

Applications for the EIT Health Regulatory Pathways to Market Bootcamp can be made until 21 May here: https://eithealth.eu/programmes/regulatory-pathways-bootcamp/

A Regulatory Pathways to Market Bootcamp meeting was held on 24 and 25 January at the IPN facilities in Coimbra, with the participation of the various partners, namely Instituto Pedro Nunes, Medical Valley EMN, Syreon Research Institute, Medtronic Iberica, Medtronic Portugal and COMPLEAR. During this meeting, the partners had the opportunity to discuss the project's next steps.


26 of January of 2024